mtDNA damage levels as a pharmacodynamic biomarker of CU-13001 efficacy
Research Grant
Administered By
Neurology, Behavioral Neurology
Awarded By
Acurex Biosciences Corporation
Start Date
June 12, 2025
End Date
October 31, 2025
Administered By
Neurology, Behavioral Neurology
Awarded By
Acurex Biosciences Corporation
Start Date
June 12, 2025
End Date
October 31, 2025